News for Atara Biotherapeutics Inc (AT2.BE)

Published at

Mar 2, 2021 4:51 AM

by seekingalpha.com

neutral

neutral

Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q4 2020 Results - Earnings Call Transcript

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q4 2020 Earnings Conference Call March 01, 2020 04:30 PM ET Company Participants Eric Hyllengren - VP, IR & Finance Pascal Touchon - President...

ATRA AT2.F AT2.BE

Read more →
Published at

Mar 2, 2021 12:25 AM

by seekingalpha.com

neutral

neutral

Atara Biotherapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation (NASDAQ:ATRA)

The following slide deck was published by Atara Biotherapeutics, Inc.

ATRA AT2.F AT2.BE

Read more →
Published at

Feb 27, 2021 5:58 PM

by benzinga.com

mixed

mixed

The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...

SRPT PFED.BA PFE.SG PFE.MX PFE.MU PFE.F PFE.DE PFE.BE PFE MRNA.MX MRNA GIS.MU GIS.F GIS.DE GIS.BE GILD.MX GILD.MI GILD BNTXN.MX BNTX AQST AB3A.SG AB3A.MU AB3A.F AB3A.BE 22UA.MU 22UA.F 22UA.DE 22UA.BE 0QF.SG 0QF.MU 0QF.F 0QF.BE XP0.SG XP0.F XFOR XENE VOR TXMD TTOO TPTX TERN SYRS SYN STIM SNSE SILK SFYC.F SFYC.BE SBBP SANA RIGL RI2A.MU RI2A.F RI2A.BE RGNX RETA RB0.MU RB0.F RB0.BE PHVS PGEN PASG PAND OSUR OPTN OPNT OMER NVV1.MU NVV1.F NVV1.BE NVAX.MX NVAX NRC.SG NRC.MU NRC.F MRK.PA MRK.MX MRK MJC.MU MJC.F MCRB LHDX LABP INO.MX INO INMB I9DN.SG I9DN.MU I9DN.F I9DN.BE I5X.F GLYC GKO.F GKO.BE GBMB.SG GBMB.MU GBMB.F GBMB.BE FOLD.MX FOLD FLGT.MX FLGT FGEN FBIO EYPT EVFM EVAX EP3.SG EP3.F EGRX DMTK.MX DMTK CXS.SG CXS.F CXS.BE CNB.F CNB.BE CLPT CHMA CCXI BOLT BHVN AXSM AVU.F AVU.BE ATXI ATRS ATRA ATNX AT2.F AT2.BE ANIK ANGN AM6.F AM6.BE AKP.F AKP.BE AGRX ADVM ADAG ACOR ABUS 7F0.F 7F0.BE 6MK.MU 6MK.F 6MK.DE 6MK.BE 69BN.SG 69BN.F 49Y.F 49Y.BE 48Q.F 3T2.MU 3T2.F 3T2.BE 3O8.MU 3O8.F 3O8.BE 2R3.F 2OW.MU 2OW.F 2OW.BE 2MT.F 2CX.SG 2CX.MU 2CX.BE 29T.F 29T.BE 1S9.SG 1S9.F 1S9.BE 1FG.F 1E6.SG 1E6.F 1AQ1.MU 1AQ1.F 1AQ1.BE 19X.SG 19X.MU 19X.F 19X.BE 0S9.F 0OP.F 0OP.BE 0AL.F 0AL.BE SPPI NTR.BE

Read more →
Published at

Feb 25, 2021 12:23 AM

by forbes.com

mixed

mixed

Steven Cohen Dives Into Chimerix

Guru adds to health care holdings with biotech focused on cancer, serious diseases

UP0.SG UP0.F RARE MRTX CXF.MU CXF.F CXF.BE CMRX BLU.TO BLU BHN0.MU BHN0.F BHN0.BE BDTX ANAB AN6.MU AN6.F 26M.SG 26M.MU 26M.F 26M.BE GXE.F GXE.DE GXE.BE GLPGF GLPG.AS DUL.MU DUL.F DUL.DE DRNA DPL.F CUSA.F CUSA.BE CRIS ATRA AT2.F AT2.BE ALNY

Read more →
Published at

Feb 24, 2021 6:02 PM

by gurufocus.com

mixed

mixed

Steven Cohen Dives Into Chimerix

Steven Cohen Dives Into Chimerix, Stocks: CMRX,ALNY,DRNA,MRTX,GLPG,CRIS,AGLE,ATRA,BLU,BDTX, Steven Cohen, release date:Feb 24, 2021

UP0.SG UP0.F RARE MRTX CXF.MU CXF.F CXF.BE CMRX BLU.TO BLU BHN0.MU BHN0.F BHN0.BE BDTX ANAB AN6.MU AN6.F 26M.SG 26M.MU 26M.F 26M.BE GXE.F GXE.DE GXE.BE GLPGF GLPG.AS DUL.MU DUL.F DUL.DE DRNA DPL.F CUSA.F CUSA.BE CRIS ATRA AT2.F AT2.BE ALNY

Read more →
Published at

Feb 24, 2021 6:02 PM

by gurufocus.com

mixed

mixed

Steven Cohen Dives Into Chimerix

Steven Cohen Dives Into Chimerix, Stocks: CMRX,ALNY,DRNA,MRTX,GLPG,CRIS,AGLE,ATRA,BLU,BDTX, Steven Cohen, release date:Feb 24, 2021

UP0.F RARE MRTX CXF.MU CXF.F CXF.BE CMRX BLU.TO BLU BHN0.MU BHN0.F BHN0.BE BDTX ANAB AN6.MU AN6.F 26M.SG 26M.MU 26M.F 26M.BE GXE.F GXE.DE GXE.BE GLPGF GLPG.AS DUL.MU DUL.F DUL.DE DRNA DPL.F CUSA.F CUSA.BE CRIS ATRA AT2.F AT2.BE ALNY

Read more →
Published at

Jan 10, 2021 10:07 PM

by marketscreener.com

positive

positive

Atara Biotherapeutics : Will Present Recent Advancements and Key Upcoming Milestones at the 39th Annual J.P. Morgan Healthcare Conference

Atara achieved significant progress across its three strategic priorities in 2020 Atara is well-positioned for success in anticipated tab-cel? regulatory submissions, approval and launch Atara... | January 10, 2021

ATRA AT2.F AT2.BE

Read more →
Published at

Jan 10, 2021 10:06 PM

by thestreet.com

neutral

neutral

Atara Biotherapeutics Will Present Recent Advancements And Key Upcoming Milestones At The 39th Annual J.P. Morgan Healthcare Conference

Atara Biotherapeutics, Inc. (Nasdaq: ATRA; the "Company"), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop

ATRA AT2.F AT2.BE

Read more →